Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE008504 |
YEM_ID: | YEM-1017 |
ID: | TCMBANKHE008504/YEM-302/YEM-1017 |
植物拉丁名: |
|
功能与主治: | To move qi and relieve pain, warm center and supplement blood./Blood vacuity, withered-yellow facial complexion, pain in heart and stomach. |
药用植物名: | 罗汉松实|短叶罗汉松 |
药名: | 小叶罗汉松 |
来源: | 云南民族药物志：第五卷 |
药用部位: | seed and floral receptacle |
使用民族: | 瑶族 |
TCM_ID_id: | 2322 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN001576 | naginataketone | C10H12O2 | 164.2 g/mol | CC1=C(OC=C1)C(=O)C=C(C)C | |
| TCMBANKIN003041 | nagilactone d | C18H20O6 | 332.3 g/mol | CCC1=C2CC3C4C(C(C5C(C4(C2=CC(=O)O1)C)O5)O)(C(=O)O3)C | |
| TCMBANKIN007938 | ipolamiide | NSC729640; NCGC00180239-01; NSC-729640; BRD-A14663384-001-01-0; ACon1_001692 | C17H26O11 | 406.4 g/mol | CC1(CCC2(C1C(OC=C2C(=O)OC)OC3C(C(C(C(O3)CO)O)O)O)O)O |
| TCMBANKIN009530 | ponasteroside a | C33H54O11 | 626.8 g/mol | CC(C)CCC(C(C)(C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)OC5C(C(C(C(O5)CO)O)O)O)O)C)C)O)O)O | |
| TCMBANKIN010665 | Inumakilactone E | 37886-71-8; inumakilactone e | C19H24O7 | 364.39 | CC(CO)C1=C2C(C3C4C(CCC(C4(C2=CC(=O)O1)C)O)(C(=O)O3)C)O |
| TCMBANKIN013804 | nagilactone e | C19H24O6 | 348.4 g/mol | CC(C)C1C23C(O2)C4C5C(C3=CC(=O)O1)(CCC(C5(C(=O)O4)C)O)C | |
| TCMBANKIN017295 | inumakilactone b | C18H18O7 | 346.3 g/mol | CC12C3C(C4C5(O4)C(OC(=O)C=C5C3(C6C(C1O)O6)C)C=C)OC2=O | |
| TCMBANKIN021415 | ipomeamarone | C15H22O3 | 250.33 g/mol | CC(C)CC(=O)CC1(CCC(O1)C2=COC=C2)C | |
| TCMBANKIN022091 | inumakilactone a | C18H20O8 | 364.3 g/mol | CC(C1C23C(O2)C4C5C(C(C6C(C5(C3=CC(=O)O1)C)O6)O)(C(=O)O4)C)O | |
| TCMBANKIN023585 | nagilactone f | C19H24O4 | 316.4 g/mol | CC(C)C1C2=CC3C4C(C2=CC(=O)O1)(CCCC4(C(=O)O3)C)C | |
| TCMBANKIN024687 | nagilactone c | C19H22O7 | 362.4 g/mol | CC(C)C1=C2C(C3C4C(C(C5C(C4(C2=CC(=O)O1)C)O5)O)(C(=O)O3)C)O | |
| TCMBANKIN027173 | inumakilactone c | C18H22O9 | 382.4 g/mol | CC(C1C2=C(C(C(=O)O1)O)C3(C4C(C2O)OC(=O)C4(C(C5C3O5)O)C)C)O | |
| TCMBANKIN027854 | inunolide | C15H20O2 | 232.32 g/mol | CC1=CCC2C(CC(=CCC1)C)OC(=O)C2=C | |
| TCMBANKIN030431 | makisterone d | C29H48O7 | 508.7 g/mol | CC(C)C(CC(C(C)(C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O)O)O)C(C)O | |
| TCMBANKIN033176 | ponasterone a | C27H44O6 | 464.6 g/mol | CC(C)CCC(C(C)(C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O)O)O | |
| TCMBANKIN035426 | makisterone B | makisterone b | C28H46O7 | 494.66 | CC(CC(C(C)(C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O)O)O)C(C)CO |
| TCMBANKIN058227 | Inokiflavone | 4H-1-Benzopyran-4-one, 6-(4-(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl)phenoxy)-5,7-dihyd- roxy-2-(4-hydroxyphenyl)-; AIDS003062; 6-(4-(5,7-Dihydroxy-4-oxo-4H-1-benzopyran-2-yl)phenoxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone; AIDS-003062; Hinokiflavone; 6-[4-(5,7-dihydroxy-4-oxo-chromen-2-yl)phenoxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; 4H-1-Benzopyran-4-one, 6-(4-(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl)phenoxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-; 6-[4-(5,7-dihydroxy-4-oxo-2-chromenyl)phenoxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-chromenone; 6-[4-(5,7-dihydroxy-4-keto-chromen-2-yl)phenoxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromone; EINECS 242-877-4; C10057; 19202-36-9; 6-[4-(5,7-dihydroxy-4-oxochromen-2-yl)phenoxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one;hinokiflavone;hinokiflavone ; SCHEMBL617273; LMPK12040004 | C30H18O10 | 538.46 g/mol | C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=C(C(=C3O)OC4=CC=C(C=C4)C5=CC(=O)C6=C(C=C(C=C6O5)O)O)O)O |
| TCMBANKIN058467 | Hinokinin | Cubebinolide; (3R,4R)-3,4-bis(1,3-benzodioxol-5-ylmethyl)-2-tetrahydrofuranone; CTK1F0599; 2(3H)-Furanone, dihydro-3,4-dipiperonyl-, trans-(-)-; hinokinin; 2(3H)-Furanone, 3,4-bis(1,3-benzodioxol-5-ylmethyl)dihydro-, (3R-trans)-; (+)-Hinokinin; DDWGQGZPYDSYEL-CABCVRRESA-N; (3R,4R)-3,4-bis(1,3-benzodioxol-5-ylmethyl)oxolan-2-one; (3R,4R)-3,4-bis(1,3-benzodioxol-5-ylmethyl)tetrahydrofuran-2-one; CHEMBL180970; 2(3H)-Furanone, 3,4-bis(1,3-benzodioxol-5-ylmethyl)dihydro-, (3S,4S)-; 3,4-Bis(1,3-benzodioxol-5-ylmethyl)dihydro-2(3H)-furanone #; 580-73-4; 26543-89-5; DTXSID40451491; (3S,4S)-3,4-BIS(2H-1,3-BENZODIOXOL-5-YLMETHYL)OXOLAN-2-ONE; C10627; ZINC900115; SCHEMBL14064757 | C20H18O6 | 354.35g/mol | C1C(C(C(=O)O1)CC2=CC3=C(C=C2)OCO3)CC4=CC5=C(C=C4)OCO5 |
| TCMBANKIN059200 | ponalactone a | 33722-77-9; AC1L9C7T; C09174; DTXSID90331734; Ponalactone A; CHEBI:8330;inumakilactone d;9, 12, 15-- octadecadienoic acid;10,13-Methyl octadecadienoate;(Cis, cis, cis)-9,12,15- octadecadienoic acid | C19H22O6 | 346.4 g/mol | CC(C)C1C2=CC3C4C(C(C5C(C4(C2=CC(=O)O1)C)O5)O)(C(=O)O3)C |
| TCMBANKIN059294 | inumakilactone a glucoside | inumakilactone a gluciside | C24H30O13 | 526.5 g/mol | CC(C1C23C(O2)C4C5C(C(C6C(C5(C3=CC(=O)O1)C)O6)O)(C(=O)O4)C)OC7C(C(C(C(O7)CO)O)O)O |
| TCMBANKIN060004 | cadinene | C15H24 | 204.35 g/mol | CC1=CCC2C(C1)C(CC=C2C)C(C)C | |
| TCMBANKIN060028 | α-ionone | C13H20O | 192.3 g/mol | CC1=CCCC(C1C=CC(=O)C)(C)C |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab